{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:21Z","timestamp":1787020161849,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2005904"],"award-info":[{"award-number":["GNT2005904"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>SARS-CoV-2 poses a considerable threat to those living in residential aged care facilities (RACF). RACF COVID-19 outbreaks have been characterised by the rapid spread of infection and high rates of severe disease and associated mortality. Despite a growing body of evidence supporting airborne transmission of SARS-CoV-2, current infection control measures in RACF including hand hygiene, social distancing, and sterilisation of surfaces, focus on contact and droplet transmission. Germicidal ultraviolet (GUV) light has been used widely to prevent airborne pathogen transmission. Our aim is to investigate the efficacy of GUV technology in reducing the risk of SARS-CoV-2 infection in RACF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicentre, two-arm double-crossover, randomised controlled trial will be conducted to determine the efficacy of GUV devices to reduce respiratory viral transmission in RACF, as an adjunct to existing infection control measures. The study will be conducted in partnership with three aged care providers in metropolitan and regional South Australia. RACF will be separated into paired within-site zones, then randomised to intervention order (GUV or control). The initial 6-week period will be followed by a 2-week washout before crossover to the second 6-week period. After accounting for estimated within-zone and within-facility correlations of infection, and baseline infection rates (10 per 100 person-days), a sample size of n\u2009=\u20098 zones (n\u2009=\u200940 residents\/zone) will provide 89% power to detect a 50% reduction in symptomatic infection rate. The primary outcome will be the incidence rate ratio of combined symptomatic respiratory infections for intervention versus control. Secondary outcomes include incidence rates of hospitalisation for complications associated with respiratory infection; respiratory virus detection in facility air and fomite samples; rates of laboratory confirmed respiratory illnesses and genomic characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Measures that can be deployed rapidly into RACF, that avoid the requirement for changes in resident and staff behaviour, and that are effective in reducing the risk of airborne SARS-CoV-2 transmission, would provide considerable benefit in safeguarding a highly vulnerable population. In addition, such measures might substantially reduce rates of other respiratory viruses, which contribute considerably to resident morbidity and mortality.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      \u00a0Australian and New Zealand Clinical Trials Registry ACTRN12621000567820 (registered on 14th May, 2021).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-06659-7","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T06:03:29Z","timestamp":1631858609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a two-arm crossover randomised controlled trial protocol"],"prefix":"10.1186","volume":"21","clinical-trial-number":[{"clinical-trial-number":"actrn12621000567820","registry":"10.18810\/anzctr"}],"author":[{"given":"Amanda","family":"Brass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5148-4063","authenticated-orcid":false,"given":"Andrew P.","family":"Shoubridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Morawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Inacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Corlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Larby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi","family":"Elms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lito E.","family":"Papanicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraint B.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"6659_CR1","doi-asserted-by":"publisher","first-page":"100771","DOI":"10.1016\/j.eclinm.2021.100771","volume":"33","author":"MR Hashan","year":"2021","unstructured":"Hashan MR, Smoll N, King C, Ockenden-Muldoon H, Walker J, Wattiaux A, et al. Epidemiology and clinical features of COVID-19 outbreaks in aged care facilities: A systematic review and meta-analysis. EClinicalMedicine. 2021;33:100771.","journal-title":"EClinicalMedicine."},{"key":"6659_CR2","doi-asserted-by":"publisher","first-page":"105730","DOI":"10.1016\/j.envint.2020.105730","volume":"139","author":"L Morawska","year":"2020","unstructured":"Morawska L, Cao J. Airborne transmission of SARS-CoV-2: The world should face the reality. Environ Int. 2020;139:105730.","journal-title":"Environ Int"},{"issue":"1","key":"6659_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5694\/mja2.51131","volume":"215","author":"Z Hyde","year":"2021","unstructured":"Hyde Z, Berger D, Miller A. Australia must act to prevent airborne transmission of SARS-CoV-2. Med J Aust. 2021;215(1):7\u20139.","journal-title":"Med J Aust"},{"issue":"12","key":"6659_CR4","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1001\/jamainternmed.2020.5225","volume":"180","author":"Y Shen","year":"2020","unstructured":"Shen Y, Li C, Dong H, Wang Z, Martinez L, Sun Z, et al. Community outbreak investigation of SARS-CoV-2 transmission among bus riders in Eastern China. JAMA Intern Med. 2020;180(12):1665\u201371.","journal-title":"JAMA Intern Med"},{"issue":"7813","key":"6659_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41586-020-2271-3","volume":"582","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature. 2020;582(7813):557\u201360.","journal-title":"Nature"},{"issue":"10285","key":"6659_CR6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(21)00869-2","volume":"397","author":"T Greenhalgh","year":"2021","unstructured":"Greenhalgh T, Jimenez JL, Prather KA, Tufekci Z, Fisman D, Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397(10285):1603\u20135.","journal-title":"Lancet"},{"key":"6659_CR7","unstructured":"Coronavirus disease (COVID-19): How is it transmitted? [Internet]. World Health Organization. 2021 [cited 23 July 2021]. https:\/\/www.who.int\/news-room\/q-a-detail\/coronavirus-disease-covid-19-how-is-it-transmitted."},{"key":"6659_CR8","doi-asserted-by":"crossref","unstructured":"Morawska L, Milton DK. Reply to Chagla et al., and Thomas. Clin Infect Dis. 2020.","DOI":"10.1093\/cid\/ciaa1121"},{"issue":"11","key":"6659_CR9","doi-asserted-by":"publisher","first-page":"e15100","DOI":"10.1371\/journal.pone.0015100","volume":"5","author":"WG Lindsley","year":"2010","unstructured":"Lindsley WG, Blachere FM, Thewlis RE, Vishnu A, Davis KA, Cao G, et al. Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS ONE. 2010;5(11):e15100.","journal-title":"PLoS ONE"},{"issue":"23","key":"6659_CR10","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1016\/j.atmosenv.2004.03.044","volume":"38","author":"IE Agranovski","year":"2004","unstructured":"Agranovski IE, Safatov AS, Pyankov OV, Sergeev AN, Agafonov AP, Ignatiev GM, et al. Monitoring of viable airborne SARS virus in ambient air. Atmos Environ. 2004;38(23):3879\u201384.","journal-title":"Atmos Environ"},{"key":"6659_CR11","doi-asserted-by":"publisher","first-page":"105832","DOI":"10.1016\/j.envint.2020.105832","volume":"142","author":"L Morawska","year":"2020","unstructured":"Morawska L, Tang JW, Bahnfleth W, Bluyssen PM, Boerstra A, Buonanno G, et al. How can airborne transmission of COVID-19 indoors be minimised? Environ Int. 2020;142:105832.","journal-title":"Environ Int"},{"issue":"6","key":"6659_CR12","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1128\/AEM.06960-11","volume":"78","author":"JJ McDevitt","year":"2012","unstructured":"McDevitt JJ, Rudnick SN, Radonovich LJ. Aerosol susceptibility of influenza virus to UV-C light. Appl Environ Microbiol. 2012;78(6):1666\u20139.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"6659_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jviromet.2004.06.006","volume":"121","author":"ME Darnell","year":"2004","unstructured":"Darnell ME, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome. SARS-CoV J Virol Methods. 2004;121(1):85\u201391.","journal-title":"SARS-CoV J Virol Methods"},{"issue":"1","key":"6659_CR14","doi-asserted-by":"publisher","first-page":"10285","DOI":"10.1038\/s41598-020-67211-2","volume":"10","author":"M Buonanno","year":"2020","unstructured":"Buonanno M, Welch D, Shuryak I, Brenner DJ. Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses. Sci Rep. 2020;10(1):10285.","journal-title":"Sci Rep"},{"issue":"4","key":"6659_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1164\/rccm.201501-0060OC","volume":"192","author":"M Mphaphlele","year":"2015","unstructured":"Mphaphlele M, Dharmadhikari AS, Jensen PA, Rudnick SN, van Reenen TH, Pagano MA, et al. Institutional tuberculosis transmission. Controlled trial of upper room ultraviolet air disinfection: a basis for new dosing guidelines. Am J Respir Crit Care Med. 2015;192(4):477\u201384.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9398","key":"6659_CR16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/S0140-6736(03)14897-0","volume":"362","author":"D Menzies","year":"2003","unstructured":"Menzies D, Popa J, Hanley JA, Rand T, Milton DK. Effect of ultraviolet germicidal lights installed in office ventilation systems on workers\u2019 health and wellbeing: double-blind multiple crossover trial. Lancet. 2003;362(9398):1785\u201391.","journal-title":"Lancet"},{"issue":"8","key":"6659_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jclinepi.2010.02.005","volume":"63","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):834\u201340.","journal-title":"J Clin Epidemiol"},{"key":"6659_CR18","unstructured":"Accessibility\/Remoteness Index of Australia Plus (ARIA+) [Internet]. Hugo Centre for Migration and Population Research, the University of Adelaide. 2016. https:\/\/www.adelaide.edu.au\/hugo-centre\/services\/aria."},{"key":"6659_CR19","unstructured":"Guidelines for the Prevention, Control and Public Health Management of Influenza Outbreaks in Residential Care Facilities in Australia [Internet]. Australian Federal Department of Health. 2017 [cited 08 July 2021]. https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cdna-flu-guidelines.htm."},{"key":"6659_CR20","unstructured":"Infectious disease control [Internet]. Government of South Australia; SA Health. 2017 [cited 08 July 2021]. https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/public+content\/sa+health+internet\/clinical+resources\/clinical+programs+and+practice+guidelines\/infectious+disease+control."},{"key":"6659_CR21","unstructured":"Prevention and control of outbreaks of seasonal influenza in long-term care facilities: a review of the evidence and best-practice guidance [Internet]. World Health Organization; Regional Office for Europe. 2017 [cited 08 July 2021]. https:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0015\/330225\/LTCF-best-practice-guidance.pdf."},{"issue":"3","key":"6659_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jcv.2009.12.010","volume":"47","author":"R Brittain-Long","year":"2010","unstructured":"Brittain-Long R, Westin J, Olofsson S, Lindh M, Andersson LM. Prospective evaluation of a novel multiplex real-time PCR assay for detection of fifteen respiratory pathogens-duration of symptoms significantly affects detection rate. J Clin Virol. 2010;47(3):263\u20137.","journal-title":"J Clin Virol"},{"issue":"10","key":"6659_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000180","volume":"25","author":"K Mizumoto","year":"2020","unstructured":"Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25(10):1.","journal-title":"Euro Surveill"},{"issue":"61","key":"6659_CR24","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1098\/rsif.2010.0686","volume":"8","author":"W Yang","year":"2011","unstructured":"Yang W, Elankumaran S, Marr LC. Concentrations and size distributions of airborne influenza A viruses measured indoors at a health centre, a day-care centre and on aeroplanes. J R Soc Interface. 2011;8(61):1176\u201384.","journal-title":"J R Soc Interface"},{"issue":"3","key":"6659_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/jamp.2010.0815","volume":"24","author":"P Fabian","year":"2011","unstructured":"Fabian P, Brain J, Houseman EA, Gern J, Milton DK. Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects. J Aerosol Med Pulm Drug Deliv. 2011;24(3):137\u201347.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"9","key":"6659_CR26","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/imj.14966","volume":"50","author":"F Crotty","year":"2020","unstructured":"Crotty F, Watson R, Lim WK. Nursing homes: the titanic of cruise ships - will residential aged care facilities survive the COVID-19 pandemic? Intern Med J. 2020;50(9):1033\u20136.","journal-title":"Intern Med J"},{"issue":"19","key":"6659_CR27","doi-asserted-by":"publisher","first-page":"6918","DOI":"10.1128\/AEM.05709-11","volume":"77","author":"TR Julian","year":"2011","unstructured":"Julian TR, Tamayo FJ, Leckie JO, Boehm AB. Comparison of surface sampling methods for virus recovery from fomites. Appl Environ Microbiol. 2011;77(19):6918\u201325.","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"6659_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/0163278703255230","volume":"26","author":"FY Hsieh","year":"2003","unstructured":"Hsieh FY, Lavori PW, Cohen HJ, Feussner JR. An overview of variance inflation factors for sample-size calculation. Eval Health Prof. 2003;26(3):239\u201357.","journal-title":"Eval Health Prof"},{"issue":"5","key":"6659_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1473-3099(09)70069-6","volume":"9","author":"J Lessler","year":"2009","unstructured":"Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9(5):291\u2013300.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"6659_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jama.2020.7603","volume":"324","author":"EA Nardell","year":"2020","unstructured":"Nardell EA, Nathavitharana RR. Airborne spread of SARS-CoV-2 and a potential role for air disinfection. JAMA. 2020;324(2):141\u20132.","journal-title":"JAMA"},{"key":"6659_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40794-018-0071-7","volume":"4","author":"ES Bailey","year":"2018","unstructured":"Bailey ES, Choi JY, Zemke J, Yondon M, Gray GC. Molecular surveillance of respiratory viruses with bioaerosol sampling in an airport. Trop Dis Travel Med Vaccines. 2018;4:11.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"6659_CR32","unstructured":"Australian Burden of Disease Study; Impact and causes of illness and death in Australia [Internet]. Australian Institute of Health and Welfare. 2016 [cited 08 July 2021]. https:\/\/www.aihw.gov.au\/getmedia\/d4df9251-c4b6-452f-a877-8370b6124219\/19663.pdf.aspx?inline=true."},{"issue":"1","key":"6659_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/003335491012500105","volume":"125","author":"NG Reed","year":"2010","unstructured":"Reed NG. The history of ultraviolet germicidal irradiation for air disinfection. Public Health Rep. 2010;125(1):15\u201327.","journal-title":"Public Health Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06659-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T06:05:08Z","timestamp":1631858708000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06659-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6659"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06659-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project has been approved by the Bellberry Limited Human Research Ethics Committee for Application Number 2021-04-403 on 15th July, 2021. A waiver of consent was granted as this study adheres to the National Health and Medical Council\u2019s National Statement on Ethical Conduct in Human Research guidelines as stated in Chapter 2.3.9 and 2.3.10.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"967"}}